|
HY-P1240B-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240A-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-138632-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P9998-1mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P9998-10mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P9998-5mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-10mg
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-100mg
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-25mg
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-5mg
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-50mg
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-19121A-1mL
|
MedChemexpress LLC
|
TCV-309 (chloride) [CAS 121494-09-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P70800-10ug
|
MedChemexpress LLC
|
TNF-Alpha/TNFSF2, Rabbit
|
|
|
|
|
HY-P70800-50ug
|
MedChemexpress LLC
|
TNF-Alpha/TNFSF2, Rabbit
|
|
|
|
|
HY-P72766-10ug
|
MedChemexpress LLC
|
B7-2/CD86, Rabbit (HEK293, His)
|
|
|
|
|
HY-P72766-50ug
|
MedChemexpress LLC
|
B7-2/CD86, Rabbit (HEK293, His)
|
|
|
|
|
HY-P99470-1mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P99470-10mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P99470-5mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
